These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11170246)

  • 1. Transgenic assays and the identification of carcinogens.
    Tennant R; Haseman J; Stoll RE
    Environ Mol Mutagen; 2001; 37(1):86-92. PubMed ID: 11170246
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the TOPKAT system for predicting the carcinogenicity of chemicals.
    Prival MJ
    Environ Mol Mutagen; 2001; 37(1):55-69. PubMed ID: 11170242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically altered mouse models for identifying carcinogens.
    Tennant RW; Stasiewicz S; Mennear J; French JE; Spalding JW
    IARC Sci Publ; 1999; (146):123-50. PubMed ID: 10353386
    [No Abstract]   [Full Text] [Related]  

  • 4. The "rodent carcinogen" dilemma: formidable challenge for the technologies of the new millennium.
    Johnson FM
    Ann N Y Acad Sci; 2000; 919():288-99. PubMed ID: 11083119
    [No Abstract]   [Full Text] [Related]  

  • 5. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and theEnvironment. Statement on ILSI/HESI research programme on alternative cancer models.
    Blain PG
    Toxicol Pathol; 2003; 31(2):254-7. PubMed ID: 12696588
    [No Abstract]   [Full Text] [Related]  

  • 6. The in vivo rodent test systems for assessment of carcinogenic potential.
    van der Laan JW; Spindler P
    Regul Toxicol Pharmacol; 2002 Feb; 35(1):122-5. PubMed ID: 11846641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thresholds in carcinogenicity in ED01 study.
    Rozman KK
    Toxicol Sci; 2003 Sep; 75(1):224-5. PubMed ID: 12923303
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro mammalian cell genotoxicity assays: their use and interpretation.
    McGregor D
    Prog Clin Biol Res; 1990; 340B():159-69. PubMed ID: 2203003
    [No Abstract]   [Full Text] [Related]  

  • 9. The International Life Sciences Institute's role in the evaluation of alternative methodologies for the assessment of carcinogenic risk.
    Robinson D
    Toxicol Pathol; 1998; 26(4):474-5. PubMed ID: 9715505
    [No Abstract]   [Full Text] [Related]  

  • 10. Neonatal mouse assay for tumorigenicity: alternative to the chronic rodent bioassay.
    Flammang TJ; Tungeln LS; Kadlubar FF; Fu PP
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):230-40. PubMed ID: 9356286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of transgenic animals for carcinogenicity testing: considerations and implications for risk assessment.
    Gulezian D; Jacobson-Kram D; McCullough CB; Olson H; Recio L; Robinson D; Storer R; Tennant R; Ward JM; Neumann DA
    Toxicol Pathol; 2000; 28(3):482-99. PubMed ID: 10862569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mouse models for the identification of human carcinogens: a European perspective.
    van Kreijl CF; van Steeg H
    Toxicol Pathol; 1998; 26(6):757-8. PubMed ID: 9864092
    [No Abstract]   [Full Text] [Related]  

  • 13. Panel discussion on the application of alternative models to cancer risk assessment.
    Pettit SD
    Toxicol Pathol; 2001; 29 Suppl():191-5. PubMed ID: 11695557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waddell's representation of the tumor incidence data of the ED01 study is strongly misleading.
    Lutz WK
    Toxicol Sci; 2003 Sep; 75(1):223; author reply 223-4. PubMed ID: 12923302
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of transgenic mice in carcinogenicity hazard assessment.
    Jacobson-Kram D; Sistare FD; Jacobs AC
    Toxicol Pathol; 2004; 32 Suppl 1():49-52. PubMed ID: 15209403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-and medium-term carcinogenicity tests: simple initiation-promotion assay systems.
    Tsuda H; Park CB; Moore MA
    IARC Sci Publ; 1999; (146):203-49. PubMed ID: 10353389
    [No Abstract]   [Full Text] [Related]  

  • 17. Evolution of the uses of rats and mice for assessing carcinogenic risk from chemicals in humans.
    Ward JM
    Asian Pac J Cancer Prev; 2010; 11(1):18. PubMed ID: 20593921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting and predicting the activity of rodent carcinogens.
    Parry JM
    Mutagenesis; 1994 Jan; 9(1):3-5. PubMed ID: 7911554
    [No Abstract]   [Full Text] [Related]  

  • 19. The utility of genetically modified mouse assays for identifying human carcinogens: a basic understanding and path forward. The Alternatives to Carcinogenicity Testing Committee ILSI HESI.
    MacDonald J; French JE; Gerson RJ; Goodman J; Inoue T; Jacobs A; Kasper P; Keller D; Lavin A; Long G; McCullough B; Sistare FD; Storer R; van der Laan JW
    Toxicol Sci; 2004 Feb; 77(2):188-94. PubMed ID: 14657512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative models for carcinogenicity testing: weight of evidence evaluations across models.
    Cohen SM
    Toxicol Pathol; 2001; 29 Suppl():183-90. PubMed ID: 11695556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.